期刊文献+

人CD59重组基因在猪血管内皮细胞中的表达 被引量:3

Expression of human recombinant CD59 gene in pig aortic endothelial cells
原文传递
导出
摘要 目的 通过转基因技术使猪的血管内皮细胞表达人CD5 9蛋白。方法 体外培养猪血管内皮细胞 ,脂质体转染法将pcDNA3 ICAM 2 Enhancer CD5 9cDNA、pcDNA3 ICAM 2 CD5 9cDNA及 pcDNA3 CMV CD5 9cDNA转染猪的血管内皮细胞 ,以未转染的猪血管内皮细胞为阴性对照 ,人的红细胞为阳性对照 ,经G418筛选 (浓度为 10 0mg/L)获得具有抗性的克隆 ,通过流式细胞仪检测转染细胞的表达情况。结果 pcDNA3 ICAM 2 Enhancer CD5 9cDNA重组质粒阳性表达强度为 61.4% ,对照组为 1.7% ,在成纤维细胞中为 8.2 %。不带增强子质粒为 3 8.3 %。结论 以人细胞间黏附因子Ⅱ (ICAM 2 )为启动子并带增强子的CD5 Objective Expressing human CD59 on the membrane of cultured pig aortic endothelial cells (PAECs) by gene transfection technieque.Methods The PAECs were cultured in vitro.The pcDNA3-ICAM-2-Enhancer-CD59cDNA and pcDNA3-ICAM-2-CD59cDNA and pcDNA3-CMV-CD59cDNA expression vector were transfected into the PAECs by lipofectinnmine mediated method.Normal PAECs served as negative control and the human erythrocytes as positive control.Stable transfecttants were selected using G418 (concentration 100 mg/L).The expression of transfected cells was assayed by flow cytometry.Results The expression intensity of CD59 expression was 61.4% in PAECs pool that was transfected by pcDNA3-ICAM-2-Enhancer-CD59cDNA,1.7% in blank control PAECs and 8.2% in fibroblast respectively.The intensity of CD59 expression was 38.3% in PAECs pool that was transfected by pcDNA3-ICAM-2-CD59cDNA.Conclusion Enhancer plus promoter of ICAM-2 could tissue-specially induce recombinant CD59 expression in PAECs.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2004年第10期1192-1193,共2页 Chinese Journal of Experimental Surgery
基金 天津市自然科学基金资助项目 (0 1 361 1 0 1 1 )
关键词 内皮细胞 基因表达 CD59基因 脂质体转染法 Endothelial cell Gene expression CD59 gene
  • 相关文献

参考文献5

  • 1Damalsso AP ,Vercelotti GM,Platt JL,et al.Inhibition of complementmediated endothelial cell cytotoxicity by decayaccelerating factor.Transplantation,1991,52:530-533.
  • 2Tom EM,Arnt EF.Xenotransplantation:How to overcome the complement obstacle? Mol Immunol ,1999,36:269-276.
  • 3Johnston PS,Wang MW,Lim SM,et al.Disscorrrdant xenografft rejection in an antibody-free model.Transplantation,1992,54:573-576.
  • 4He Z,She R ,Sumitran-Holgersson S,et al .The in vitro activity and apecificity of human endothelial cell-specific promoter in procine cells .Xenotransplantation,2001,8:202-212.
  • 5Brovimans RA,Wieringen PAM,Van Es LA,et al,Relative role of decay-acclerating factor,membrane cofactor,and CD59 in the protection of human endothelial cells against complement mediated lysis.Eur J Immunol,1992,22:3135-3140.

同被引文献13

  • 1Brovimans RA, Wierngen OAM, Van Es LA, et al, Relatiiv roles of decay-accelerating factor, membrane cofactor, and CD59 in the protecttion of human endothelial cells against complement lysis. Eur J Immunol, 1992,22:3135-3140.
  • 2Tom EM,Amt EF. Xenotransplantion: how to overcome the complent obstacle.9 Mol lmmuuol, 1999,36:269-276.
  • 3Johnston PS,Wang MW,Lim SM ,et al. Disseorrrdant xenografft rejection in an antibody-free model. Transplantation, 1992,54:573-576.
  • 4Tone M, Diamond LE, Walsh LA. High level transcription of the complement regulatory protein CD59 requires an enhancer located in intron I. J Biol Chem,1999,274:710-716.
  • 5He Z,She R,Sumitran-Holgersson S,et al. The in vitro activity and apecificity of human endothelial cell-specific promoter in procine cells. Xenotransplantation, 2001,8 : 202 -212.
  • 6Gordon JW, Scangos GA, Plotkin D J, et al. Genetic transferation of mouse embryos by microinjection of purified DNA. Proc Amd Natl Sci USA, 1980,77 : 1250-1254.
  • 7Hogan B, Constantini F, Lacy E, et al. Manipulating the mouse embryo: a laboratory mamual. New York: Cold Spring Harbor Laboratory, 1986.151.
  • 8J.萨姆布鲁克主编.金东雁 梨孟枫译.分子克隆试验指南.第2版[M].北京:科学出版社,2002.481.
  • 9Nagahama M, Shiraishi M, Oshiro T, et al. Adenovirus-mediated gene transfer of triple human complement regulating proteins( DAF,MCP and CD59) in the xenogeneic porcine-to-human transplantation model. PartⅠ: in vitro assays using porcine aortic endothelial cells. Transpl Int, 2002, 15(5):205.
  • 10Costa C, Zhao L, Burton WV, et al. Transgenic pigs designed to express human CD59 and H-transferase to avoid humoral xenograft rejection. Xenotransplantation, 2002, 9( 1 ):47.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部